Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)

CONCLUSION: Atezolizumab plus carboplatin and pemetrexed demonstrates activity in patients with advanced nonsquamous NSCLC with untreated brain metastases with an acceptable safety profile.PMID:37603816 | DOI:10.1200/JCO.22.02561

Source: Clinical Lung Cancer - August 21, 2023 Category: Cancer & Oncology Authors: Ernest Nadal Delvys Rodr íguez-Abreu Marta Sim ó Bartomeu Massut í Oscar Juan Gerardo Huidobro Rafael L ópez Javier De Castro Anna Estival Joaqu ín Mosquera Ivana Sullivan Enriqueta Felip Ana Blasco Maria Guirado Eva Pereira Noelia Vilari ño Valent Source Type: research